Oleanolic acid 및 그 유도체가 MC3T3-E1 조골세포주의 분화에 미치는 효과
Effects of Oleanolic Acid and its Derivatives on the Differentiation of MC3T3-E1 Osteoblastic Cell
0
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
Ursolic acid, triterpenoid compound has been shown to stimulate osteoblast differentiation and enhance bone formation. In the present study, we examined the effects of similar triterpenoid compounds, oleanolic acid (OA) and its derivatives, such as oleanolic acid acetate (OAA) and oleanolic acetate methyl ester (OAM) on the bone formation in MC3T3-E1 osteoblast cells. We determined cellular proliferation, alkaline phosphatase (ALP) activity, mineralization, and expression of osteoblast specific genes and mitogen activated protein kinase phosphorylation. Treatment of 0.1-10μM OA,OAA, and OAM increased cellular proliferation, but not significantly increased as compared with dimethyl sulfoxide (DMSO). OA, OAA, and OAM at 5uM concentration enhanced ALP expression, mineralization, and osteocalcin (OCN)mRNA level. In conclusion, OA and its derivatives stimulated the osteoblast differentiation by increasing ALP, mineralization,and OCN mRNA expression. However, there were no significantly difference on osteoblast differentiation among treatment of OA, OAA, and OAM.
Abstract
Ursolic acid, triterpenoid compound has been shown to stimulate osteoblast differentiation and enhance bone formation. In the present study, we examined the effects of similar triterpenoid compounds, oleanolic acid (OA) and its derivatives, such as oleanolic acid acetate (OAA) and oleanolic acetate methyl ester (OAM) on the bone formation in MC3T3-E1 osteoblast cells. We determined cellular proliferation, alkaline phosphatase (ALP) activity, mineralization, and expression of osteoblast specific genes and mitogen activated protein kinase phosphorylation. Treatment of 0.1-10μM OA,OAA, and OAM increased cellular proliferation, but not significantly increased as compared with dimethyl sulfoxide (DMSO). OA, OAA, and OAM at 5uM concentration enhanced ALP expression, mineralization, and osteocalcin (OCN)mRNA level. In conclusion, OA and its derivatives stimulated the osteoblast differentiation by increasing ALP, mineralization,and OCN mRNA expression. However, there were no significantly difference on osteoblast differentiation among treatment of OA, OAA, and OAM.
참고문헌 (38)
- Anderson JJ, "Phytoestrogen and bone", Bailliere's Clinical Endocrinology and Metabolism, 12, pp.543~557 (1998)
- Bachhav SS, "Oleanolic acid prevents glucocorticoid-induced hypertension in rats", Phytotherapy Research, 25, pp.1435~1439 (2011)
- Byers BA, "Exogenous Runx2 expression enhances in vitro osteoblastic differentiation and mineralization in primary bone marrow stromal cells", Tissue Engineering, 10, pp.1623~1632 (2004)
- Boonen A, "The prevention of treatment of age related osteoporosis in the elderly by systemic recombinant growth factor therapy (rhIGF-I or rhRGF-β): a perspective", Journal of Internal Medicine, 242, pp.285~290 (1997)
- Bradford MM, "A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding", Analytical Biochemistry, 72, pp.248~254 (1976)
- Byers BA, "Exogenous Runx2 expression enhances in vitro osteoblastic differentiation and mineralization in primary bone marrow stromal cells", Tissue Engineering, 10, pp.1623~1632 (2004)
- Christian JC, "Heritability of bone mass: a longitudinal study in aging male twins", The American Journal of Human Genetics, 44, pp.429~433 (1989)
- Cheng SL, "A dominant negative cadherin inhibits osteoblast differentiation", Journal of Bone and Mineral Research, 15, pp.2362~2370 (2000)
- Cheung WM, "Dimethyl sulfoxide as an inducer of differentiation in preosteoblast MC3T3-E1 cells", FEBS Letters, 580, pp.121~126 (2006)
- Cho SH, "The effects of 17-β estradiol, medroxyprogesterone acetate and parathyroid hormone on the differentiation of osteoblast cell", Korean Journal of Obstetrics & Gynecology, 39, pp.1497~1506 (1996)
- Delmas PD, "Treatment of postmenopausal osteoporosis", Lancet, 359, pp.2018~2026 (2002)
- Dinkova-Kostova AT, "Extremely potent triterpenoid inducers of the phase 2 response: correlations of protection against oxidant and inflammatory stress", Proceedings of the National Academy of Sciences of the United States of America, 12, pp.4584~4589 (2005)
- Ebeling PR, "Bone turnover markers and bone density across the menopausal transition", The Journal of Clinical Endocrinology & Metabolism, 81, pp.3366~3371 (1996)
- Hauschka PV, "Osteocalcin and matrix Gla protein: vitamin K-dependent proteins in bone", Physiological Reviews, 69, pp.990~1047 (1989)
- Hipskind RA, "MAP kinase signaling cascades and gene expression in osteoblasts", Frontiers in Bioscience, 3, pp.804~816 (1998)
- Hanai Y, "The involvement of p44", p42 MAP kinase in insulin-like growth factor-I-induced alkaline phosphatase activity in osteoblast like MC3T3-E1 cells, 2006, pp.251, 42~48
- 지숙희, "머위(Petasites japonicus)와 여주(Momordica charantia L.) 추출물의 MC3T3-E1 조골세포 증식 및 분화에 미치는 효과", 한국식품영양과학회지, 39(2), pp.203~209 (2010), 한국식품영양과학회
- Jie L, "Pharmacology of oleanolic acid and ursolic acid", Journal of Ethnopharmacology, 49, pp.57~68 (1995)
- Jeong JG, "Low concentration of 3-carene stimulates the differentiation of mouse osteoblastic MC3T3-E1 subclone 4 cells", Phytotherapy Research, 22, pp.18~22 (2008)
- Ji Hae Jun, "Bone Morphogenetic Protein 2-induced MAPKs Activation Is Independent of the Smad1", 5 Activation, 2009, pp.34(2), 115~121[DOI]
- Kwak HB, "Tanshinone IIA isolated from Salvia miltiorrhiza Bunge inhibits osteoclast differentiation and bone resorption", Korean Journal of Medicinal Crop Science, 14, pp.146~147 (2006)
- 권지웅, "복분자 에탄올 추출물의 생리활성 탐색", 한국약용작물학회지, 19(5), pp.325~333 (2011), 한국약용작물학회
- Kleerekoper M, "Sodium fluoride therapy of postmenopausal osteoporosis", Endocrine Reviews, 14, pp.312~323 (1993)
- Kozawa O, "Divergent regulation by p44", p42 MAP kinase and p38 MAP kinase of bone morphogenetic protein-4-stimulated osteocalcin synthesis in osteoblasts, 2002, pp.84, 583~589
- Lee SU, "Anabolic activity of ursolic acid in bone: Stimulating osteoblast differentiation in vitro and inducing new bone formation in vivo", PHARMACOLOGICAL RESEARCH, 58, pp.290~296 (2008), ACADEMIC PRESS LTD ELSEVIER SCIENCE LTD
- Lips P, "Vitamin D deficiency and secondary hyperpar athyroidism in the elderly: consequences for bone loss and fractures and therapeutic implications", Endocrine Reviews, 22, pp.477~501 (2001)
- Liu J, "New insights into generalized hepatoprotective effects of oleanolic acid: key roles of metallothionein and Nrf2 induction", Biochemical Pharmacology, 76, pp.922~928 (2008)
- Maeda T, "Simvastatin promotes osteoblast differentiation and mineralization in MC3T3-E1 cells", Biochemical and Biophysical Research Communications, 280, pp.874~877 (2001)
- Musabayane CT, "Synergistic antihyperglycemic effects between plant-derived oleanolic acid and insulin in streptozotocin-induced diabetic rats", Renal Failure, 32, pp.832~839 (2010)
- Marumo K, "Effects of parathyroid hormone (teriparatide) on bone mass and quality in osteoporosis", Japanese Journal of Clinical Medicine, 69, pp.1264~1269 (2011)
- Owen TA, "Progressive development of the rat osteoblast phenotype in vitro: Reciprocal relationships in expression of genes associated with osteoblast proliferation and differentiation during formation of the bone extracellular matrix", Journal of Cellular Physiology, 143, pp.420~430 (1990)
- Parfitt AM, "Osteonal and hemi-osteonal remodeling: The spatial and temporal framework for signal traffic in adult human bone", Journal of Cellular Biochemistry, 55, pp.273~286 (1994)
- 이인선, "미역취(Solidago virga-aurea var. gigantea Miq.)뿌리 추출물이 MC3T3-E1 조골세포의 활성과 분화에 미치는 영향", 한국식품영양과학회지, 34(7), pp.929~936 (2005), 한국식품영양과학회
- Pittenger JJ, "Multilineage potential of adult human mesenchymal stem cells", Science, 284, pp.143~147 (1999)
- Sudo H, "In vitro differentiation and calcification in new clonal osteogenic cell line derived from newbone mouse calvaria", The Journal of Cell Biology, 96, pp.191~198 (1983)
- Suda T, "Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families", Endocrine Reviews, 20, pp.345~357 (1999)
- Zhou R, "Inhibition of mTOR signaling by oleanolic acid contributes to its anti-tumor activity in osteosarcoma cells", Journal of Orthopaedic Research, 29, pp.846~852 (2011)
- Zhang Y, "Synthesis and activity of oleanolic acid derivatives, a novel class of inhibitors of osteoclast formation", Bioorganic & Medicinal Chemistry Letters, 15, pp.1629~1632 (2005)
